Tissue engineering: The design and fabrication of living replacement devices for surgical reconstruction and transplantation

Lancet

Volumn 354, Issue SUPPL.1, 1999, Pages 32-34

  Vacanti, Joseph P ^a   Langer, Robert ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

BIOENGINEERING; BIOREACTOR; CARTILAGE; CELL DIFFERENTIATION; HUMAN; PLASTIC SURGERY; PRIORITY JOURNAL; SHORT SURVEY; STEM CELL; TISSUE CULTURE; VASCULARIZATION;

EID: 0032803699     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(99)90247-7     Document Type: Article

References (26)

1. Langer R, Vacanti JP, Tissue engineering: the challenges ahead. Sci Am 1999; 280: 62-65.
2. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260: 920-26.
3. Bisceglie, V. Uber die antineoplastische immunitat; heterologe Einpflanzung von Tumoren in Huhner-embryonen. Ztschr f Krebsforsch 1933; 40: 122-140.
4. Chick, WL, Like AA, Lauris V. Beta cell culture on synthetic capillaries: an artificial endocrine pancreas. Science 1975; 187: 847-48.
5. Bell E, Ehrlich P, Buttle DJ, Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent of full thickness. Science 1981; 221: 1052-54.
6. Burke JF, Yannas IV, Quimby WC, Bondoc CC, Jung WK. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 1981; 194: 413-48.
7. Vacanti JP, Morse MA, Saltzman WM, Domb AJ, Perez-Atayde A, Langer R. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 1988; 23: 3-9.
8. Mooney DJ, Mikos AG. Growing new organs. Sci Am 1999; 280: 38-43.
9. Lysaght MJ, Nguy NAP, Sullivan K. An economic survey of the emerging tissue engineering industry. Tissue Eng 1998; 4: 231-38.
10. Barrera DA, Zylstra E, Lansbury PT, Langer R. Synthesis and RGD peptide modification of a new biodegradable coplymer (polylactic acid-co-lysine). J Am Chem Soc 1993; 115: 11010-11.
11. Vacanti CA, Langer R, Schloo B, Vacanti JP. Synthetic polymers seeded with chrondocytes provide a template for new cartilage formation. Plastic Reconstr Surg 1991; 88: 733-59.
12. Shinoka T, Shumtin D, Ma PX, et al. Creation of viable pulmonary artery autografts through tissue engineering. J Thor Cardiovasc Surg 1998; 45: 536-45.
13. Niklason LE, Gao J, Abbott WM, et al. Functional arteries grown in vivo. Science 1999; 284: 489-93.
14. Organ GM, Mooney DJ, Hansen LK, Schloo B, Vacanti JP. Transplantation of enterocytes utilizing polymer-cell constructs to produce neointestine. Transplant Proc 1992; 24: 3009-11.
15. Vacanti CA, Cima LG, Ratkowski D, Upton J, Vacanti JP. Tissue engineered growth of new cartilage in the shape of a human ear using synthetic polymers seeded with chondrocytes. In: Cima LG, Ron ES, eds. Tissue-inducing biomaterials, Materials Research Society Symposium Proceedings (Vol 252). Pittsburgh: Materials Research Society, 1992: 367-74.
16. Isogai N, Landis W, Kim TH, Gerstenfeld LC, Upton J, Vacanti JP. Tissue engineering of a phalangeal joint for application in reconstructive hand surgery. J Bone Joint Surg Am 1999; 81: 306-16.
17. Shinoka T, Ma PX, Shum-Tim D, et al. Tissue engineered heart valves. Circulation 1996; 94 (suppl II): 164-68.
18. Diamond DA, Caldamone AA. Endoscopic treatment of vesicoureteric reflux in children using autologous chondrocytes. American Association of Pediatrics Annual Meeting, San Francisco, CA, USA. October 1998, abstract 107, 176-77.
19. Mayhew TA, Williams GR, Senica MA, Kuniholm G, Du Moulin GC. Validation of a quality assurance program for autologous cultured chondrocyte implantation. Tissue Eng 1998; 4: 325-34.
20. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-47.
21. Mitaka T, Sato F, Mizuguchi T, Yokono T, Mochizuki Y. Reconstruction of hepatic organoid by rat small hepatocytes and hepatic nonparenchymal cells. Hepatology 1999; 29: 111-25.
22. Faustman D, Coe C. Prevention of xenograft rejection by masking donor HLA class I antigens. Science 1991; 252: 1700-02.
23. Pakzaban P, Deacon TW, Burns LH, Dinsmore J, Isacson O. A novel mode of immunoprotection of neural xenotransplants: masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system. Neuroscience 1995; 65: 983-96.
24. Vunjak-Novakovic G, Freed L, Biron RJ, Langer R. Effects of mixing on the composition and morphology of tissue-engineered cartilage. Am Inst Chem Eng J 1996; 42: 850-60.
25. Mooney D, Kaufmann PM, Sano K, et al. Localized delivery of EGF improves the survival of transplanted hepatocytes. Biotechnol Bioeng 1996; 50: 427-29.
26. Griffith LG, Wu B, Cima MJ, Powers MJ, Chaignaud B, Vacanti JP. In vitro organogenesis of liver tissue. Ann NY Acad Sci 1997; 831: 382-97.